Connection

Michael Lilly to Bortezomib

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Bortezomib.
Michael Lilly
Connection Strength
0.095
Bortezomib
  1. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther. 2011 Jul 15; 12(2):119-24.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.